Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Zhang

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Haematology|February 23, 2018
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaKyle R Crassini, Eva Zhang, Shalini Balendran, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2022
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and managementSasha R Fehily, Aysha H Al-Ani, Jonathan Abdelmalak, et al.
Gastrohep|September 20, 2021
SARS-CoV-2 vaccination in patients with inflammatory bowel diseaseRalley E Prentice, Clarissa Rentsch, Aysha H Al-Ani, et al.
Gut|March 6, 2023
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatmentsEva Zhang, Thi H O Nguyen, Lilith F Allen, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Haematology|February 23, 2018
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaKyle R Crassini, Eva Zhang, Shalini Balendran, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2022
Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression-risks, screening, diagnosis and managementSasha R Fehily, Aysha H Al-Ani, Jonathan Abdelmalak, et al.
Gastrohep|September 20, 2021
SARS-CoV-2 vaccination in patients with inflammatory bowel diseaseRalley E Prentice, Clarissa Rentsch, Aysha H Al-Ani, et al.
Gut|March 6, 2023
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatmentsEva Zhang, Thi H O Nguyen, Lilith F Allen, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Pageof 2